Nucl Med Mol Imaging.  2014 Sep;48(3):241-243. 10.1007/s13139-014-0278-0.

Evaluation of Flap Tissue Viability by F-18 FDG PET/CT

Affiliations
  • 1Department of Nuclear Medicine, Seoul National University Bundang Hospital, 82, Gumi-Ro 173 Beon-Gil, Bundang-Gu, Seongnam-Si, Gyeonggi-Do 463-707, Korea. debobkr@gmail.com
  • 2Department of Plastic Surgery, Seoul National University Bundang Hospital, Seongnam-Si, Korea.

Abstract

A 60-year-old man underwent vertical rectus abdominis myocutaneous flap to reconstruct a left lateral chest wall defect. For assessment of viability of muscle flap, F-18 fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) was performed 15 days after surgery. The FDG PET/CTshowed a small metabolic defect in the left lateral chest wall. During follow-up, necrotic change of the graft was observed, and the site was in accordance with the area where the metabolic defect was observed in the FDG PET/CT. As a result, debridement and wound closure was performed. This case suggested that the FDG PET/CT should be a usefulmethod for the monitoring of muscle viability after flap surgery.

Keyword

Fluorine-18-fluorodeoxyglucose; Positron emission tomography; Myocutaneous flap; Tissue viability

MeSH Terms

Debridement
Electrons
Fluorodeoxyglucose F18
Follow-Up Studies
Humans
Middle Aged
Myocutaneous Flap
Positron-Emission Tomography
Positron-Emission Tomography and Computed Tomography*
Rectus Abdominis
Thoracic Wall
Tissue Survival*
Transplants
Wounds and Injuries
Fluorodeoxyglucose F18
Full Text Links
  • NMMI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr